Woodard Investments logo
Portfolio

Investments

We make direct investments in early-stage companies and maintain selective fund exposure to deepen sector knowledge and access.

Eovision

Clinician-led decision-support platform for second medical opinions.

2025 · Direct · AI · Healthcare · Seed

Ethermed

AI-powered prior authorization for payers and providers.

2025 · Direct · AI · Healthcare · Series A

Promaxo

Office-based MRI platform expanding access to diagnostic imaging.

2025 · Direct · Healthcare · Series B

Building something meaningful?

We invest from Pre-Seed to Series A. Share your deck and we'll respond quickly with a clear answer.